Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04486326 · ClinicalTrials.gov registry record · Phase 4
Crofelemer for Functional Diarrhea
A Phase 4 study, sponsored by Beth Israel Deaconess Medical Center.
- Terminated
- Registry status
- Phase 4
- Development phase
- 17
- Enrollment target
NCT04486326 is a Phase 4 study that was terminated before completion, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 17 participants.
The verdict
NCT04486326, a Phase 4 study, was terminated before completion, sponsored by Beth Israel Deaconess Medical Center.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 17 participants
- Enrollment target
Study Summary
The primary objectives of this study are to evaluate the clinical response of patients with diarrhea to crofelemer relative to placebo and evaluate the overall safety and tolerability of crofelemer in the treatment of diarrhea.
Interventions
- DRUG Placebo
- DRUG Crofelemer
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2020-08-20 |
| Est. Completion | 2022-09-23 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04486326
The ClinicalTrials.gov registry entry for NCT04486326 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 17 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Beth Israel Deaconess Medical Center, which has 488 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT04486326 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04486326 about?
NCT04486326 is a clinical study titled "Crofelemer for Functional Diarrhea". The primary objectives of this study are to evaluate the clinical response of patients with diarrhea to crofelemer relative to placebo and evaluate the overall safety and tolerability of crofelemer in the treatment of diarrhea.
What is the current status of trial NCT04486326?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 17 participants. The study started on 2020-08-20. Estimated completion is 2022-09-23.
What interventions are being tested in trial NCT04486326?
The interventions under investigation include: Placebo (DRUG), Crofelemer (DRUG).
Who is sponsoring clinical trial NCT04486326?
This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.